• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Mechanism of Renal Injury Induced by Metabolic Factors and Prevention of the Injury by Vasoprotective Factors.

Research Project

Project/Area Number 14571044
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionNational Cardiovascular Center Research Institute

Principal Investigator

SUGA Shinichi  National Cardiovascular Center Research Institute, Department of Etiology and Pathogenesis, Laboratory Chief, 病因部, 室長 (70273456)

Co-Investigator(Kenkyū-buntansha) KISHIMOTO Ichiro  National Cardiovascular Center Research Institute, Department of Biochemistry, Laboratory Chief, 生化学部, 室長 (80312221)
Project Period (FY) 2002 – 2003
Keywordsrenal tubulointerstitial injury / hypokalemic nephropathy / hypoxia / endothelin / angiotensin II / adrenomedullin / ischemic / reperfusion / diabetic nephropathy
Research Abstract

■Hypokalemic Nephropathy
(1)We demonstrated an up-regulation of endothelin (ET)-1 production in the cortex and medulla, and an increase in the expression of the ET type A receptor (ETA) and type B receptor (ETB) in the medulla of rats with hypokalemic nephropathy. ETA blockade ameliorated renal tubulointerstitial injury and renal function in hypokalemic nephropathy. ETA blockade ameliorated renal ET-1 production. By contrast, ETB blockade suppressed renal ET-1 production and ETA expression as well as improved renal tubulointerstitial injury and renal ET-1 production and ETA expression as well as improved renal tubulointerstitial injury and renal function in hypokalemic nephropathy. These results suggested that ET-1 can induce renal injury not only via direct activation of ETA, but also by stimulating local production of ET-1 via ETB.
(2)We also demonstrated that angiotensin II antagonism ameliorates tubulointerstitial injury and renal function in hypokalemic nephropathy, and suggested that renal angiotensin II generation may contribute to the pathogenesis of hypokalemic tubulointerstitial injury.
■Renoprotection by Vasoactive Factors : Adrenomedullin, a potent vasorelaxing peptide and a prosurvival factor for vascular cells, ameliorates tubular necrosis and apoptosis in ischemic reperfusion injury of the kidney possibly by suppressing renal production of TNF-α and interleukin-6.
■Searching New Candidate Genes for Diabetic Nephropathy : We found an alteration in the expression of genes related to kidney development and podocyte structure as well as glucose and lipid metabolism and oxidative stress in db/db mice, a model of type 2 diabetes, when compared to the control. This alteration might be related to pathogenesis of early diabetic glomerulopathy.

  • Research Products

    (14 results)

All Other

All Publications (14 results)

  • [Publications] Suga S, et al.: "Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium-deficiency."Kidney International. 61・3. 951-958 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Suga S, et al.: "Endothelin A receptor blockade and endothelin B receptor blockade improve hypokalmic nephropathy by different mechanisms."Journal of the American Society of Nephrology. 14・2. 397-406 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tokudome K, et al.: "Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism."Endocrinology. 143. 3515-3521 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Nakagawa T, et al.: "Tubulointerstitial disease : Role of ischemia and microvascular disease."Current Opinion in Nephrology and Hypertension. 12. 233-241 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Horio T, et al.: "Gene expression, secretion, and autocrine action of C-type natriuretic peptide in cultured adult rat cardiac fibroblasts."Endocrinology. 144. 2279-2284 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tokudome K, et al.: "Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy : interference between CNP and endothelin-1 signaling pathways."Endocrinology. 145. 2131-2140 (2004)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] S.Suga, M.Mazzali, P.E.Ray, D.H.Kang, R.J.Johnson: "Angiotensin II Type 1 Receptor Blockade Ameliorates Tubulointerstitial Injury Induced by Chronic Potassium-Deficiency."Kidney Int.. 61. 951-958 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Tokudome, T.Horio, F.Yoshiwara, S.Suga, Y.Kawano, M.Kohno, K.Kangawa: "Adrenomedullin inhibits doxorubicin-induced cultured rat cardiac myocyte apoptosis via a cAMP-dependent mechanism."Endocrinology. 143. 3515-3521 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] S.Suga, N.Yasui, F.Yoshihara, T.Horio, Y.Kawano, K.Kangawa, R.J.Johnson: "Endothelin A receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms."J Am Soc Nephrol.. 14. 397-406 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Horio, T.Tokudome, T.Maki, F.Yoshihara, S.Suga, T.Nishikimi, M.Kojima, Y.Kawano, K.Kanagawa: "Gene Expression, Secretion, and Autocrine Action of C-type Natriuretic Peptide in Cultured Adult Rat Cardiac Fibroblasts."Endocrinology. 144. 2279-2284 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Nakagawa, D.H.Kang, R.Ohashi, S.Suga, J.Herrera-Acosta, B.Rodriguez-Iturbe, R.J.Johnson: "Tubulointerstitial Disease : Role of Ischemia and Microvascular Disease."Current Opinion Nephrol Hypertens.. 12. 233-241 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Tokudome, T.Horio, M.Fukunaga, H.Okumura, J.Hino, K.Mori, F.Yoshihara, S.Suga, Y.Kawano, M.Kohno, K.Kangawa: "Ventricular nonmyocytes inhibit doxorubicin-induced myocyte apoptosis : involvement of endogenous endothelin-1 as a paracrine factor."Endocrinology. 145. 2458-2466 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Tokudome, T.Horio, T.Soeki, K.Mori, I.Kishimoto, S.Suga, F.Yoshihara, Y.Kawano, M.Kohno, K.Kanagawa: "Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy : interference between CNP and endothelin-1 signaling pathways."Endocrinology. 145. 2131-2140 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] T.Tokudome, T.Horio, F.Yoshihara, S.Suga, Y.Kawano, M.Kohno, K.Kanagawa: "Different effects of high glucose and insulin on cultured cardiac myocyte hypertrophy and fibroblast proliferation."Metabolism. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi